-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Sabra Health Care REIT, Raises Price Target to $22

Benzinga·11/11/2026 21:21:03
UBS analyst Michael Goldsmith maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and raises the price target from $20 to $22.